Found: 15
Select item for more details and to access through your institution.
Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α.
- Published in:
- 2012
- By:
- Publication type:
- journal article
A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Sunscreen use and duration of sun exposure: a double-blind, randomized trial.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines.
- Published in:
- Oncogene, 2012, v. 31, n. 13, p. 1683, doi. 10.1038/onc.2011.360
- By:
- Publication type:
- Article
A Phase II Study with 5-Fluorouracil, Folinic Acid and Oxaliplatin (FOLFOX-4 Regimen) in Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Oncology, 2003, v. 64, n. 1, p. 25, doi. 10.1159/000066518
- By:
- Publication type:
- Article
Addition of Bevacizumab to Temsirolimus in Kidney Cancer Patients.
- Published in:
- Case Reports in Oncology, 2011, v. 4, n. 3, p. 531, doi. 10.1159/000334581
- By:
- Publication type:
- Article
Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib.
- Published in:
- British Journal of Cancer, 2013, v. 108, n. 4, p. 887, doi. 10.1038/bjc.2012.548
- By:
- Publication type:
- Article
Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α.
- Published in:
- British Journal of Cancer, 2012, v. 106, n. 10, p. 1587, doi. 10.1038/bjc.2012.149
- By:
- Publication type:
- Article
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET.
- Published in:
- Medical Oncology, 2010, v. 27, n. 3, p. 899, doi. 10.1007/s12032-009-9303-z
- By:
- Publication type:
- Article
Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma: a Federation Nationale des Centres de Lutte Contre le Cancer Multicenter, parallel study.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Safety and efficacy of subcutaneous and continuous intravenous infusion rIL-2 in patients with metastatic renal cell carcinoma.
- Published in:
- British Journal of Cancer, 2004, v. 90, n. 6, p. 1156, doi. 10.1038/sj.bjc.6601709
- By:
- Publication type:
- Article
Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002).
- Published in:
- British Journal of Cancer, 2003, v. 89, p. S59, doi. 10.1038/sj.bjc.6601085
- By:
- Publication type:
- Article
Cutaneous melanoma.
- Published in:
- British Journal of Cancer, 2001, v. 84, p. 81, doi. 10.1054/bjoc.2001.1771
- By:
- Publication type:
- Article
Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients.
- Published in:
- Clinical & Experimental Immunology, 2000, v. 119, n. 1, p. 28, doi. 10.1046/j.1365-2249.2000.01112.x
- By:
- Publication type:
- Article